Document is current

Article History

Received: 11 November 2020

Accepted: 16 March 2021

First Online: 23 March 2021

Declarations

:

: This study was approved by the ethics committees at Tachibana Medical Corporation Higashisumiyoshi-Morimoto Hospital (approved on May 15, 2018) and Kyoto Pharmaceutical University (No.19–18-02) with which the authors are affiliated. The present study was a prospective observational study as part of daily practice without intervention at the treatment, therefore researchers are not necessarily required to receive written informed consent. However, a written form describing the objectives and methods of this study approved by the ethics committees was explained all study participants to obtain verbal consent and we prepared a record of the informed consent received.

: Not applicable.

: The authors declare that they have no competing interests.